Largest biotech by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Kodiak Sciences has the lowest figure of the 24 biotech ranked by total assets, at SAR 1.3B, followed by Scholar Rock Holding (SAR 1.5B) and ImmunityBio (SAR 1.9B). Figures as of 18 Nov 2026, 16:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- Kodiak SciencesSAR 1.3B
- Median
- SAR 9.6B
- Combined market value
- SAR 3.15T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Kodiak SciencesKOD · Health Care | SAR 1.3B | SAR 23.7B | SAR 363.17 | 0.02% up | 396% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | SAR 1.5B | SAR 21.6B | SAR 176.67 | 4.48% up | 14% up | ||
| 3 | ImmunityBioIBRX · Health Care | SAR 1.9B | SAR 26.4B | SAR 24.79 | 5.59% up | 193% up | ||
| 4 | Adaptive BiotechnologiesADPT · Health Care | SAR 1.9B | SAR 17.2B | SAR 106.00 | 0.81% down | 88% up | ||
| 5 | Twist BioscienceTWST · Health Care | SAR 2.4B | SAR 29.6B | SAR 434.18 | 3.35% up | 340% up | ||
| 6 | CG OncologyCGON · Health Care | SAR 3B | SAR 26.8B | SAR 299.82 | 1.25% up | 85% up | ||
| 7 | ImmunovantIMVT · Health Care | SAR 3.6B | SAR 26.1B | SAR 125.92 | 1.08% up | 43% up | ||
| 8 | Krystal BiotechKRYS · Health Care | SAR 5B | SAR 34.5B | SAR 1,163.04 | 3.86% up | 46% up | ||
| 9 | Kymera TherapeuticsKYMR · Health Care | SAR 6.5B | SAR 38.7B | SAR 453.83 | 0.44% down | 87% up | ||
| 10 | CRISPR TherapeuticsCRSP · Health Care | SAR 8.5B | SAR 15.2B | SAR 156.87 | 4.16% up | 21% down | ||
| 11 | Revolution MedicinesRVMD · Health Care | SAR 8.8B | SAR 130.4B | SAR 602.75 | 1.23% down | 131% up | ||
| 12 | Halozyme TherapeuticsHALO · Health Care | SAR 9.5B | SAR 41.5B | SAR 364.24 | 1.18% up | 37% up | ||
| 13 | Bio-TechneTECH · Health Care | SAR 9.7B | SAR 42.9B | SAR 272.81 | 0.14% up | 26% up | ||
| 14 | ExelixisEXEL · Health Care | SAR 10.7B | SAR 63.3B | SAR 259.42 | 0.96% up | 63% up | ||
| 15 | RepligenRGEN · Health Care | SAR 11.1B | SAR 41.1B | SAR 642.43 | 5.60% up | 5% up | ||
| 16 | VaxcytePCVX · Health Care | SAR 11.3B | SAR 35B | SAR 221.27 | 0.69% down | 22% up | ||
| 17 | Neurocrine BiosciencesNBIX · Health Care | SAR 17.4B | SAR 61.8B | SAR 610.81 | 1.86% down | 20% up | ||
| 18 | QiagenQGEN · Health Care | SAR 23.6B | SAR 38.4B | SAR 185.84 | 0.41% down | 12% up | ||
| 19 | argenxARGX · Health Care | SAR 32.6B | SAR 222.5B | SAR 3,538.07 | 0.45% down | 4% up | ||
| 20 | ModernaMRNA · Health Care | SAR 46.3B | SAR 305.9B | SAR 755.96 | 2.55% down | 755% up | ||
| 21 | BioNTechBNTX · Health Care | SAR 91.5B | SAR 78.2B | SAR 315.48 | 0.89% down | 16% down | ||
| 22 | BiogenBIIB · Health Care | SAR 110.4B | SAR 138.6B | SAR 937.49 | 0.34% down | 49% up | ||
| 23 | Gilead SciencesGILD · Health Care | SAR 221.4B | SAR 788.3B | SAR 635.59 | 0.48% down | 33% up | ||
| 24 | AmgenAMGN · Health Care | SAR 339.8B | SAR 906.8B | SAR 1,676.43 | 2.40% down | 34% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which biotech have the lowest total assets?
Kodiak Sciences (SAR 1.3B), Scholar Rock Holding (SAR 1.5B) and ImmunityBio (SAR 1.9B) have the lowest total assets of the 24 biotech ranked here as of 18 Nov 2026, 16:31 UTC.
How many biotech are in this ranking?
24 are ranked by total assets.
What are these biotech worth together?
The 24 biotech ranked by total assets have a combined market value of SAR 3.15T as of 18 Nov 2026, 16:31 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.